Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc.

Overview
Date Founded

1983

Headquarters

660 WEST GERMANTOWN PIKE, PLYMOUTH MEETING, PA, 19462, USA

Type of Company

Public

Employees (Worldwide)

262

Industries

Pharmaceuticals
Biotechnology
Hospitals & Patient Services

Company Description

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline include VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Contact Data
Trying to get in touch with decision makers at Inovio Pharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Founder

Chief Financial Officer & Principal Accounting Officer

Chief Operating Officer & Executive Vice President

Chief Scientific Officer

Senior Vice President-Clinical Development

Senior Vice President, Regulatory Affairs

Senior Vice President, Clinical Development

Senior Vice President, Alliance & Program Management

Senior Vice President, Business Development

Senior Vice President, R&D

Board of Directors

Former Executive Vice President at Merck-Medco Managed Care LLC

Former President, Chief Executive Officer & Director at Ilypsa, Inc.

Founder at Inovio Pharmaceuticals, Inc.

Auditor & Certified Public Accountant at Ernst & Young Global Ltd.

Former Chief Marketing Officer & Executive Vice President at Merck & Co., Inc.

Former Executive Director-Global Marketing at Amgen, Inc.

Chief Medical Officer at Seagen Inc.

Executive Vice President at The Wistar Institute

Paths to Inovio Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Inovio Pharmaceuticals, Inc.
Owners & Shareholders
Details Hidden

Avidity Partners Management LP (APM) is a hedge fund manager headquartered in Dallas, Texas founded by Michael David Gregory. APM provides investment advice.

Details Hidden

Seven Eight Capital’s strategy focuses on trading a wide number of liquid equity securities and futures contracts that trade on established US markets. The Firm's investment strategies are market-neutral and based on a set of methods known as statistical arbitrage. The process consists of investing in a broad portfolio of liquid securities for a short duration. Seven Eight Capital has broad discretion in making investments and will generally consist of global equity securities and other assets that may be affected by business, financial market or legal uncertainties. The Firm may invest a portion of its assets in the stocks of companies with small-to medium-sized market capitalizations and may pursue relative value strategies by taking long positions in securities believed to be undervalued and short positions in securities believed to be overvalued.

Details Hidden

Cedar Brook Group utilizes a combination of fundamental, technical, cyclical and behavioral finance methods of analysis while employing an asset allocation strategy based on a derivative of Modern Portfolio Theory (MPT). The firm primarily allocates client assets among various mutual funds, exchange-traded funds (ETFs), individual debt and equity securities, options and independent investment managers in accordance with their stated investment objectives.

Recent Transactions
Details Hidden

Inovio Pharmaceuticals, Inc. issued USD Common Stock

Details Hidden

Inovio Pharmaceuticals, Inc. purchases GeneOne Life Science, Inc.

Details Hidden

Inovio Pharmaceuticals, Inc. issued USD Common Stock

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Underwriter

Advised onInovio Pharmaceuticals, Inc. issued USD Common Stock

Underwriter

Advised onInovio Pharmaceuticals, Inc. issued USD Common Stock

Escrow Agent

Advised onInovio Pharmaceuticals, Inc. issued USD Common Stock

Professional

Advised onInovio Pharmaceuticals, Inc. issued USD Common Stock

Legal Advisor

Advised onInovio Pharmaceuticals, Inc. issued USD Common Stock

Legal Advisor

Advised onInovio Pharmaceuticals, Inc. issued USD Common Stock

Advisors & Consultants

Partner at Duane Morris LLP

Legal Advisor

Partner at Olshan Frome Wolosky LLP

Clients

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA.

GeneOne Life Science, Inc. engages in the research, development, and manufacture of deoxyribonucleic acid (DNA) vaccines for the prevention and treatment of diseases. Its products include VGX-3400, VGX-3500, and fluprime. Its service include process cost analysis, sterility testing, research batch production, strain selection, cell bank characterization, and others. It also conduct pre-clinical trials for the treatment of hepatitis C. In addition, it is involved in the contract manufacturing activities for pre-clinical and clinical trials for companies and institutions. The company was founded on January 27, 1976 and is headquartered in Seoul, South Korea.

Key Stats and Financials As of 2020
Market Capitalization
$1.43B
Total Enterprise Value
$1B
Earnings Per Share
$-1.07
Revenue
$7.41M
EBITDAMargin
-1,698.16%
Enterprise Value / Sales
134.97x
TEVNet Income
-6.01x
Debt TEV
0.04x
Total Equity
$461M
Total Debt
$39M
EBITDA
$-126M
Net Profit
$-166M
Three Year Compounded Annual Growth Rate Of Revenue
-44.01%
Non-Profit Donations & Grants
$5,000 - $10K
2018
$2,500 - $4,999
2017
$10K - $25K
2017
Non-Profit Donations & Grants Received
Investments
Details Hidden

Geneos Therapeutics, Inc. Develops and commercializes neo-antigen based personalized cancer therapies. The firm engages in developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells. The company was founded by Niranjan Y. Sardesai in 2017 and is headquartered in Plymouth Meeting, PA.

Suppliers
GeneOne Life Science, Inc. Textiles | Seoul, South Korea

GeneOne Life Science, Inc. engages in the research, development, and manufacture of deoxyribonucleic acid (DNA) vaccines for the prevention and treatment of diseases. Its products include VGX-3400, VGX-3500, and fluprime. Its service include process cost analysis, sterility testing, research batch production, strain selection, cell bank characterization, and others. It also conduct pre-clinical trials for the treatment of hepatitis C. In addition, it is involved in the contract manufacturing activities for pre-clinical and clinical trials for companies and institutions. The company was founded on January 27, 1976 and is headquartered in Seoul, South Korea.

Regeneron Pharmaceuticals, Inc. Pharmaceuticals | Tarrytown, New York

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Ology Bioservices, Inc. Hospitals & Patient Services | Alachua, Florida

Ology Bioservices, Inc. engages in the development of biopharmaceutical products and medical devices. It also offers preclinical and clinical development, formulation optimization, and cGMP manufacturing. The company was founded by James D. Talton in 1999 and is headquartered in Alachua FL.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

AstraZeneca Plc Pharmaceuticals - Cambridge, United Kingdom

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Inovio Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Inovio Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Inovio Pharmaceuticals, Inc..